Buprenorphine And Naloxone Tablet
Product Images NDC 87441-001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 87441-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Uds Buprenorphine Label)

This is a description of Buprenorphine and Naloxone sublingual tablets, USP. Each tablet contains 8 mg of Buprenorphine Hydrochloride and 2 mg of Naloxone Hydrochloride. These tablets should be stored at 20° to 25°C. It is essential to keep this product out of the reach of children as accidental ingestion may require emergency medical care. The medication is distributed by TUCKAHOE ENTERPRISES, LLC, with address locations in Raleigh, NC, and Henrico, VA.*

FDA Label Image

Chemical Structure (Buprenorphine 01)

FDA Label Image

Chemical Structure (Buprenorphine 02)

FDA Label Image

Image (Buprenorphine 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.